ELAN
Elanco Animal Health
NYSE: ELAN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$21.80
-1.58% today
Updated 2026-04-29
Market cap
$10.89B
P/E ratio
—
P/S ratio
2.31x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$9 – $28
Volume
5.1M
WallStSmart proprietary scores
51
out of 100
Grade: C
Hold
Investment rating
6.7
Growth
B5.3
Quality
C+3.0
Profitability
D5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
0.9
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$28.57
+31.06%
12-Month target
—
—
Intrinsic (DCF)
$31.06
Margin of safety
+17.22%
4 Strong Buy10 Buy2 Hold0 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $46.00M — positive
+ Revenue growth 12.20% QoQ
+ 17.22% below intrinsic value
Risks
- Altman Z 0.90 — distress zone
- Thin margins at -4.92%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $4.41B | $4.42B | $4.44B | $4.71B | $4.71B |
| Net income | $-78.00M | $-1.23B | $338.00M | $-232.00M | $-276.00M |
| EPS | — | — | — | — | $-0.47 |
| Free cash flow | $268.00M | $117.00M | $394.00M | $284.00M | $46.00M |
| Profit margin | -1.77% | -27.87% | 7.61% | -4.92% | -4.92% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-17 | VANHIMBERGEN, ROBERT M | Buy | 8 | $23.68 |
| 2026-04-17 | SIMMONS, JEFFREY N | Buy | 119 | $23.68 |
| 2026-04-17 | MODI, RAJEEV A. | Buy | 62 | $23.68 |
Peer comparison
Smart narrative
Elanco Animal Health trades at $21.80. Our Smart Value Score of 51/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 0.90, it sits in the distress. TTM revenue stands at $4.71B. with profit margins at -4.92%. Our DCF model estimates intrinsic value at $31.06.
Frequently asked questions
What is Elanco Animal Health's stock price?
Elanco Animal Health (ELAN) trades at $21.80.
Is Elanco Animal Health overvalued?
Smart Value Score 51/100 (Grade C, Hold). DCF value $31.06.
What is the price target of Elanco Animal Health (ELAN)?
The analyst target price is $28.57, representing +31.1% upside from the current price of $21.80.
What is the intrinsic value of Elanco Animal Health (ELAN)?
Based on our DCF model, intrinsic value is $31.06, a +17.2% margin of safety versus $21.80.
What is Elanco Animal Health's revenue?
TTM revenue is $4.71B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
0.90 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio2.31x
ROE-3.67%
Beta1.88
50D MA$23.95
200D MA$21.42
Shares out0.50B
Float0.49B
Short ratio—
Avg volume5.1M
Performance
1 week-1.38%
1 month-5.50%
3 months-8.17%
YTD-2.12%
1 year—
3 years—
5 years—